Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Theralase Technologies Inc (TLT) NPV

Sell:0.22 CAD Buy:0.23 CAD Change: No change
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Sell:0.22 CAD
Buy:0.23 CAD
Change: No change
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Sell:0.22 CAD
Buy:0.23 CAD
Change: No change
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Theralase Technologies Inc. is a biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds (PDCs) to destroy cancer. The Company operates through two divisions: Therapeutic Laser Technology (TLT) division and Photo Dynamic Therapy (PDT) division. The TLT division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology is used for healing a range of nerve, muscle and joint conditions, including arthritis, osteoarthritis and wounds. The PDT division develops PDCs and activates them with laser technology to destroy specifically targeted cancers and bacteria. Its TLC-2000 Biofeedback Therapeutic Laser Technology possesses Cell Sensing technology that senses and targets injured tissue. It is also developing TLC-1000 therapeutic medical laser system. It is developing TLC-3000 medical laser system for the treatment of a range of cancers.

Contact details

Address:
41 Hollinger Rd
EAST YORK
M4B 3G4
Canada
Telephone:
+1 (416) 6995273
Website:
theralase.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TLT
ISIN:
CA88337V1004
Market cap:
40.86 million CAD
Shares in issue:
204.28 million
Sector:
Health Care Equipment
Exchange:
Canadian Venture Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Shawn Shirazi
    Chief Executive Officer
  • Kristina Hachey
    Chief Financial Officer, Director
  • Arkady Mandel
    Chief Scientific Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.